'Healthcare products regulatory agency' diaporamas de présentation

Healthcare products regulatory agency - PowerPoint PPT Presentation

Sheena Helyer 12.2012 BA.RGN.DN. PGCE. Nurse Prescriber.

Sheena Helyer 12.2012 BA.RGN.DN. PGCE. Nurse Prescriber.

HSC 3047: Part 1 Support the use of medication in social care settings: Legislation, classification and responsibilities. Sheena Helyer 12.2012 BA.RGN.DN. PGCE. Nurse Prescriber. Photos supplied by: gename.fieldofscience.com, allcareprofessionals.com. Learning outcomes for HSC 3047.

★ ★ ★ ★ ★

1.16k views • 33 slides
Blood Transfusion

Blood Transfusion

Blood Transfusion. Medical Staff 2011. Regulations. Medicines and Healthcare Products Regulatory Agency (MHRA) EU Directive 2005/61/EC (100% compliance) NHSLA Induction Annual Update NPSA competencies (3 yearly).

★ ★ ★ ★ ★

861 views • 22 slides
Serious adverse events following falsely high glucose measurements resulting from administration of an IGIV product cont

Serious adverse events following falsely high glucose measurements resulting from administration of an IGIV product cont

Serious adverse events following falsely high glucose measurements resulting from administration of an IGIV product containing maltose. L. Ross Pierce, M.D. Medical Officer, Clinical Review Branch, Div. of Hematology, FDA.

★ ★ ★ ★ ★

321 views • 14 slides
Serious Adverse Events Following Falsely Elevated Glucose Measurements Resulting from Administration of an IGIV Produ

Serious Adverse Events Following Falsely Elevated Glucose Measurements Resulting from Administration of an IGIV Produ

Serious Adverse Events Following Falsely Elevated Glucose Measurements Resulting from Administration of an IGIV Product Containing Maltose. BPAC Meeting, Gaithersburg, MD, November 4, 2005. Adverse Event Case Report Summary. Ann Gaines, PhD, MT(ASCP) Division of Epidemiology

★ ★ ★ ★ ★

218 views • 13 slides
10 Great Buy Spain melanotan store Public Speakers

10 Great Buy Spain melanotan store Public Speakers

Melanotan II is supposed for individuals with skin issues or have a lack of pigment. As we say in the post, Melanotan is being assessed in rigorous clinical trials, a few of which have discovered promising outcomes. We aren't criticising Melanotan itself, however we are involved about unregulated and illegal use. The proven fact that stories about possible side-effects amongst some melanotan users are appearing within the media is a worry, and solely serves to spotlight the uncertainties around these injections and the need for correct studies.

★ ★ ★ ★ ★

23 views • 2 slides

View Healthcare products regulatory agency PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Healthcare products regulatory agency PowerPoint presentations. You can view or download Healthcare products regulatory agency presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.